Istituto Oncologico Veneto — Clinical Trial Site

417 Registered trials

176 Currently recruiting

Organisation

Istituto Oncologico Veneto

Location

Padova, Italy

Identifier

ORG-100007494

Address

Via Gattamelata 64, 35128, Italy

Departments

"Istituto Oncologico Veneto – IRCCS Medical Oncology 1 Unit"
#1907:U.O.C. Oncologia 2
#2000: Oncologia Medica 1
#4102: UOC Oncologia 1
#4105;UOC Oncologia Medica 2
#8019:U.O.C. Oncoematologia
039013: UO Oncologia Medica II
03910:UOC Oncologia 2
0401: UOC Oncologia 2
1801: Oncologia Medica 1
2608: UOC OncoematologiaIOV IRCCS Castelfranco Veneto c/o Osp San Giacomo
39004: Oncologia Medica 3
4101: Oncologia Medica 2
4102: UO Oncologia Medica II
4103:Oncologia Medica 2
4104: Department of Clinical and Experimental Oncology
4104: UOC Oncologia 3
4105: Melanoma Oncology Unit
4105:Oncologia Medica 2
4107: UOC Oncologia 2 - Dipartimento Oncologia
4109; Department of Clinical and Experimental Oncology
4111: UOC Oncologia Medica 2
4204: UOC Oncologia Medica 1
Anestesia e Rianimazione
Centro Sperimentazioni di Fase 1
Centro Sperimentazioni di Fase I, UOC Oncologia 2
chirurgia oncologica
Chirurgia Oncologica dei Tessuti Molli, del Peritoneo e dei Melanomi
CLINICAL AND EXPERIMENTAL ONCOLOGY
DEPARTMENT OF CLINICAL AND EXPERIMENTAL ONCOLOGY
Department of Clinical and Experimental Oncology, Department of Medical Oncology 1
Department of Oncology
Department of Oncology, Oncology 1
Department of Surgery, Oncology and Gastroenterology
DIPARTIMENTO DI MEDICINA CLINICA 1
Dipartimento di Medicina Clinica 1 - UOC EMATOLOGIA
DIPARTIMENTO DI MEDICINA CLINICA 1 - UOC ONCOEMATOLOGIA
Dipartimento di Oncologia Medica
Dipartimento di Scienze Chirurgiche
Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche
DIPARTIMENTO MEDICINA GENERALE E SPECIALISTICO
Ematologia
Experimental & Clinical Oncology
IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II
Istituto Oncologico Veneto
ISTITUTO ONCOLOGICO VENETO IRCCS
IT001A
ITA009: UOC Oncologia Medica 1
Medical Oncologi Unit 1
Medical Oncology
Medical Oncology 1
Medical Oncology 1 Unit
Medical Oncology 2
Medical Oncology unit 1
Medical Oncology Unit 2
Melanoma Oncology Unit
n/a
Neuro-Oncology-Neuroscience
Not applicable
Onclogy, Medical Oncology 1 Unit
onclologia medica
ONCOEMATOLOGIA
Oncoematologia IOV
Oncohematology Unit
Oncohematology Unit and Transplant Unit
Oncologia
Oncologia 2
Oncologia 1
Oncologia 2
Oncologia 3
Oncologia del Melanoma
Oncologia ed Ematologia
Oncologia I
Oncologia Media
Oncologia Medica
Oncologia Medica 1
Oncologia Medica 2
Oncologia Medica I
Oncologia Medica II
Oncologia Medica Seconda
Oncologia Toracica
Oncology
Oncology 2
Oncology 1
Oncology 1 Unit
Oncology 1 Unit – Veneto Institute of Oncology - IRCCS
Oncology 2
Oncology Department
Oncology Dept
Oncology Unit
Oncology Unit 2
Oncology Unit 3
Operating Unit of Medical Oncology 2
Radiologia Oncologica
Radioterapia
Radiotherapy
S.C. Oncologia 1
S.S. Neoplasie Gastroenteriche - S.C. Oncologia Medica
S.S. Oncologia Urogenitale
S.S.D. Sperimentazioni Cliniche di Fase Precoce
SC Ematologia
SC Oncologia 1
SC Oncologica Medica 1
Scienze Chirurgiche, Oncologiche e Gastroenterologiche (DiSCOG)
Second Medical Oncology Unit
SOC Oncologia Medica
SSD Oncologia del Melanoma
SSD Oncologia del Melanoma e dell’Esofago
SSD Oncologia Melanoma ed Esofago
U. O. di Oncologia Medica 1
U.O. Melanoma e Sarcomi
U.O. Oncologia 2
U.O. Oncologia Medica
U.O. Oncologia Medica 1
U.O.C Oncology 2
U.O.C. di Oncologia Medica 2
U.O.C. Oncoematologia
U.O.C. Oncologia 1
U.O.C. Oncologia 2
U.O.C. Oncologia Medica 1
U.O.C. Oncologia Medica 2
U.O.C. Oncologia Medica 2 I
U.O.C. Oncology 2
U.O.S.D. Oncologia del Melanoma
Unita di Oncologia Medica
Unità di Oncologia Medica 1
Unità Operativa Complessa di Oncologia Medica 2
Unità Operativa Complessa Oncologia Medica 1
Unita Operativa di Oncologia Medica I
Unità Operativa Oncologia Medica 1
Unita` Operativa Complessa Oncologia 3
UO Oncologia
UO Oncologia 1
UO Oncologia Medica II
UOC Chirurgia, Oncologia e Gastroenterologia
UOC di Oncologia Medica
UOC di Oncologia Medica 2
UOC Medical Oncology Unit 1
UOC Oncoematologia
UOC Oncologia
UOC Oncologia 1
UOC Oncologia 2
UOC Oncologia 3
UOC Oncologia 3 - Dipartimento di Oncologia
UOC Oncologia Medica
UOC Oncologia Medica 1
UOC Oncologia Medica 1 Dipartimento di Oncologia Clinica e Sperimentale
UOC Oncologia Medica 2
UOC Oncologia Medica II
UOC Oncologia Medica II, Istituto Oncologico Veneto IRCCS
UOC Oncologica Medica 1
UOC ONCOLOGY 1
UOC Oncology 1,
UOC Oncology 2
UOC Urologia Oncologica
UOS Oncologia Toracica UOC. Oncologia Medica 2
UOSD Oncologia del Melanoma
UOSD Sperimentazioni Cliniche di Fase Precoce
UOSD Tumori ereditari
UOSD Tumori Ereditari ed Endocrinologia Oncologica
Urologia
Urologia Oncologica
USD Sperimentazioni Cliniche Di Fase Precoce, UOC Oncologia 3

Clinical trials at this site (417)

Search interface

Multicenter phase II study of preoperative chemoradiotherapy with CApecitabine plus Temozolomide in patients with MGMT silenced and microsat… Recruiting

2024-513931-26-00 locally advanced rectal cancer (LARC) 4 2021-12-01
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally adva… Recruiting

2024-513820-40-00 Metastatic or locally advanced leiomyosarcoma 4 2021-10-29
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting

2023-505163-37-00 Metastatic Colorectal Cancer 3 2021-10-01
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 metastatic colorectal cancer 4 2021-07-01
Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting

2024-512982-15-00 BRCA Mutated Ovarian Cancer Patients, Epithelian ovaria 5 2021-06-28
“A phase II, single arm study investigating neoadjuvant plus adjuvant treatment with Cemiplimab in surgically resectable, high risk stage II… Recruiting

2024-515204-39-00 surgically resectable, high risk stage III/IV (M0) Cuta 4 2021-02-10
Phase 1b/2 trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treat… Recruiting

2024-515580-64-00 metastatic colorectal cancer 7 2020-12-31
The study is aimed at evaluating the feasibility of a hypomethylating treatment combined with hematopoietic stem cell transplantation in com… Recruiting

2023-510515-19-00 Higher-risk-myelodysplastic syndromes 5 2020-11-27
NeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced recta… Recruiting

2024-519007-10-00 Locally advanced stage II/III rectal cancer 10 2020-10-22
“A phase II randomized non-comparative study, with NEOadjuvant plus adjuvant Therapy with combination or sequence of vemurafenib, cobImetini… Recruiting

2024-516659-41-00 high-risk, surgically resectable BRAF mutated and wild- 4 2020-10-12
A study of Trastuzumab Deruxtecan to assess its safety, tolerability, immune response, and inhibition of tumor activity when given alone or … Recruiting

2023-504888-16-00 Patients with Human Epidermal Growth Factor Receptor 2 9 2020-10-05
Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting

2023-510433-29-00 Favorable-intermediate-risk Acute Myeloid Leukemia 5 2020-09-24
Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal… Recruiting

2024-514542-37-00 Select advanced solid tumors and Non-Small Cell Lung Ca 9 2020-08-13
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
Study to identify the most appropriate therapy for patients with Acute Myeloid Leukemia carrying FLT3 mutation, using the PBC biomarker to c… Recruiting

2023-505901-17-00 Acute Myeloid Leukemia (LMA) with FLT3 mutation 5 2020-04-24
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting

2023-508302-24-00 Locally Advanced/Metastatic Urothelial Cancer 4 2019-05-07
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine… Ended

2023-505829-14-00 First recurrence glioblastoma 5 2026-06-02
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 10 2025-12-17
Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Ended

2024-517817-34-00 Gastric Cancer 9 2025-06-18
Evaluation of the safety and efficacy of the drug Veonetinib (AL8326) in the post-first treatment of small cell lung cancer, non small cell … Ended

2023-509067-24-01 - Small Cell Lung Cancer (SCLC) patients who need ≥2nd 4 2025-06-17
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC) Ended

2024-517818-15-00 Non-Small Cell Lung Cancer 9 2025-06-06
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Ended

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16